Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-651114
  • Global Digital PCR Market Research, PCR Reaction Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • Publish: September 2016 | Report Code: HME-651114

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

PCR is used in serious research areas such as gene appearance analysis, virus-related quantitative analysis, HIV DNA finding and genotyping etc. have given valued data to the field of healthcare. PCR allows quantification and discovery of marker DNA. PCR allows quantification and discovery of marker DNA. PCR is an appreciated tool in diagnosis, experimental trials and medicine research The Global Digital Polymerase Chain Reaction (dPCR) market is projected to grow with a CAGR of 37% from 2016 to 2022.  Technological advancement is the key driver of the global digital polymerase chain reaction market growth. As dpcr is the advanced version of polymerase chain reaction. Dpcr is more reliable and sensitive technique to quantify the exact amount of nucleic acid or DNA or RNA in the sample. Thus, helps in studying variations such as copy number variants in gene sequencing and widely adopted for clonal amplification for next-generation sequencing in samples. Global dpcr market is primarily driven by following factors:

  • INCREASING INCIDENTS OF INFECTIOUS DISEASES AND GENETIC DISORDERS
  • RISING GERIATRIC POPULATION
  • ADVANCEMENT IN TECHNOLOGY
  • INCREASING PUBLIC–PRIVATE INVESTMENTS AND GRANTS
  • RISE IN THE NUMBER OF HOSPITALS AND DIAGNOSTICS CENTERS






The key driver of the market is growing number of infectious diseases and genetic disorder cases worldwide. For example, according to world health organization, globally, 36.7 million were there with HIV in the year 2015. And it has been estimated that more than 0.8% of adults with the age of 15-49 years are living with HIV worldwide. Sub-saharan Africa is most affected, accounts about 70% of the total people living with HIV worldwide. Moreover, 1.1 million died of AIDS related illness in 2015. Moreover in 2015, there were more than 10.4 million new TB cases worldwide.

Quantitative PCR (qPCR) is being used mainly by bio-pharma and educational organization labs. However, dPCR are getting more focus currently.  dPCR provide advanced level of accuracy and greater sensitivity. This can directly affect the time span of FDA approvals. The growth of the dPCR market is driven by factors such as increasing geriatric population, advancements in technology, increasing incidents of infectious diseases and hereditary disorders, and increment in public-private investments and grants. Still, issues such as high cost of digital PCR devices and limitations of dPCR methods are restraining the growth of this market. Attempts for acceptance, implementation of MIQE guidelines for publishing dPCR-based research is giving an important challenge for the growth of the digital PCR (dPCR) market.

Source: OBRC Analysis

The global dpcr market segments includes technology, products and services. Technology is further segmented into:

  • Digital pcr
  • Quantitative pcr



The application segment is categorized into:

  • Clinical
  • Research
  • Forensic




The product and services sement is categorized into:

  • Instrument
  • Reagents and consumables
  • Software and services




The end-user segment is categorized into:

  • Research laboratories and academic institutes
  • Hospitals and diagnostic centers
  • Pharmaceuticals and biotechnology companies
  • Clinical research organizations
  • Forensic laboratories






The revenue for the above application and enduser segments are specific to the dpcr market. However, the total revenue of these application and endusers in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up technology and product & services segment.

Geographically, the global dpcr market has been segmented on the basis of four major region, which include:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





On the basis of technology, PCR market is segmented into quantitative PCR and digital PCR. The quantitative PCR segment was expected to count for higher share of the digital PCR market in 2015. The robust market standing of this technology segment is attributed to the continuing automation of laboratory techniques including integration of robotics with dPCR, growing adoption of dPCR among researchers and healthcare specialists coupled with increased funding, grants, and public-private investments for dPCR-based researches and large installation base of dPCR instruments. On the basis of product and services, dPCR products are categorized into dPCR tools and equipment, reagents, consumables, and software and services. The quantitative PCR reagents and consumables sector is expected to account for the major share of the global qPCR products and services market in 2016. However, the digital PCR instruments section is expected to grow at the highest CAGR in the global dPCR products and services market during the future years. The procedural benefits provided by dPCR over qPCR, rising market demand for dPCR particularly in forensics and medicine drug finding, and increasing number of dPCR-based research through the worldwide are the contributing factors to the growth of the dPCR instruments sector. On the basis of application digital PCR is sub segmented in clinical application, research applications and forensic applications. Research workshop and academic organization, hospitals and diagnostic hubs, pharmaceutical and biotechnology companies, clinical research organizations and forensic laboratories are the main end-users of the global PCR market.

Geographically, the market has been segmented mainly in four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). North America is expected to hold the higher market share in the global digital PCR market in 2016, and then by Europe. Many factors such as rising geriatric population, increase in public and private organization funding support and federal associations for the research and development of innovative quantitative PCR and digital PCR products are driving the digital PCR market in the North America. Asia-Pacific geography (covering India, China, Japan, and the Rest of Asia-Pacific) is projected to be the fastest-growing region in the digital PCR market during the future years, due to collective focus of global life sciences companies in these countries having  high efforts to increase attentiveness related to gene-based syndrome diagnosis and treatment and growing public and private organization support to develop novel qPCR and dPCR technologies.

The major market players of the global dpcr market are:

  • AFFYMETRIX, INC.
  • AGILENT TECHNOLOGIES, INC.
  • BIOMÉRIEUX S.A.
  • BIO-RAD LABORATORIES, INC.
  • HOFFMAN-LA ROCHE LTD
  • FLUIDIGM CORPORATION
  • OTHERS








Detailed analysis of these companies provided in this report comprises Overview, SCOT Analysis, Product Portfolio, Strategic Initiative and Strategic Analysis.

The global digital PCR (dPCR) market is very competitive with a high number of international as well as national market players. These companies using various strategies such as merger & acquisition, collaboration, partnership and product launching. The global digital PCR (dPCR) market was dominated by Bio-Rad Laboratories Inc. (U.S.A.), Thermo Fisher Scientific Inc. (U.S.A.), and F. Hoffmann-La Roche, Ltd. (Switzerland), which together accounted for about 70 percent of the market. Companies taking strategic initiative such as partnership collaboration for latest technology use, acquisition for more market capture and new product development for portfolio enhancement. In a strategic move, BioMérieux has acquired Hyglos. The company has researched on a method and developed an innovative technique for recombinant proteins, which removes the necessity for horseshoe crab blood and thus permits for the finding of the presence of endotoxins using a chain of fully standardized responses. Hyglos expertise in the area of recombinant proteins unlocks different horizons for the discovery of endotoxins. Its current product portfolio offering of biological control facility for the health industry and medical devices.

Why to buy the report:

This report will provide you:

  • Provide you the business strategies adopted by market player such as
  • Provide in detail the different segments such as by technology, application, products & services and end-users which are affecting the global dpcr market.
  • Provide you the patent analysis of the dpcr market.
  • Identify, understand, and the strength, opportunities, challenges and threat of the dpcr market.
  • Provide revenues of major players of the market such as thermos fisher and F. Hoffmann-La Roche .
  • Provide you various the regulatory policies which are affecting the global dpcr market.







How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global dpcr market offers the longest chain of market segmentation covering major market segmentation based on product & services and application. The report tracks the major market trends in the global dpcr market such as instrument and reagents & consumables, software and services and so on.  For each market segments covered in global dpccr market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the smart security industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data. 

Key Findings of the global smart security market:

  • Increasing adoption of dpcr such as growing number of communicable diseases and genetic disorder are  fuelling growth in global dpcr market.
  • North America is anticipated to account the largest revenue share in 2016.
  • Product and services segment is the dominating market due to growing adoption of consumables and instruments in experiments and tests.
  • Increasing government support
  • Partnership is the key strategy adopted by the various market players of global dpcr market.
  • Consumables is the major segment of product and services. 
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. : EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. INCREASING INCIDENTS OF INFECTIOUS DISEASES AND GENETIC DISORDERS 
3.1.2. .    RISING GERIATRIC POPULATION
3.1.3. .    ADVANCEMENT IN TECHNOLOGY
3.1.4. .    INCREASING PUBLIC–PRIVATE INVESTMENTS AND GRANTS
3.1.5. .    RISE IN THE NUMBER OF HOSPITALS AND DIAGNOSTICS CENTERS
3.2. MARKET RESTRAINTS
3.2.1. HIGH DEVICE COSTS ASSOCIATED WITH DPCR 
3.2.2. LACK OF SKILLED LABOR AND INEFFICIENT DATA ANALYSIS TOOLS
3.3. MARKET OPPORTUNITIES
3.3.1.  .    INCREASING MARKET PENETRATION IN DEVELOPING COUNTRIES
3.3.2. .     SHIFT FROM PLANT-DERIVED TO GENOME-BASED DRUG DISCOVERY
3.4.  MARKET CHALLENGES 
3.4.1. IMPLEMENTATION OF MIQE GUIDELINES FOR PUBLISHING DPCR-BASED RESEARCH
3.4.2. .     INCREASING COMPETITION FROM NEWER TECHNOLOGIES SUCH AS NGS IS LIKELY TO HAMPER THE GROWTH OF PCR INSTRUMENTS
 
4. MARKET SEGMENTATION 
4.1. GLOBAL DIGITAL PCR MARKETBY  TECHNOLOGY
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT 
4.1.3. DATABASE & ESTIMATION METHODOLOGY
4.1.4. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.5. OPPORTUNITY MATRIX
4.1.6. MARKET SEGMENTATION 
4.1.6.1. GLOBAL DIGITAL PCR (DPCR) MARKET  MARKET
4.1.6.1.1. APPLICATION
4.1.6.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.6.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.6.1.4. TOP PLAYERS & KEY PRODUCTS 
4.1.6.1.5. KEY CONCLUSIONS
4.1.6.2. GLOBAL  QUANTITATIVE PCR (QPCR) MARKET
4.1.6.2.1. APPLICATION
4.1.6.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.6.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.6.2.4. TOP PLAYERS & KEY PRODUCTS 
4.1.6.2.5. KEY CONCLUSIONS
4.2. GLOBAL DIGITAL PCR MARKETBY APPLICATION
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL  CLINICAL APPLICATION MARKET
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS 
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL  RESEARCH APPLICATION MARKET
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS 
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL  FORENSIC APPLICATION MARKET
4.2.5.3.1. APPLICATION
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS 
4.2.5.3.5. KEY CONCLUSIONS
4.3. GLOBAL DIGITAL PCR MARKETBY  PRODUCTS AND SERVICES
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL   INSTRUMENTS MARKET
4.3.5.1.1. APPLICATION
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS 
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. GLOBAL   REAGENTS AND CONSUMABLES MARKET
4.3.5.2.1. APPLICATION
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS 
4.3.5.2.5. KEY CONCLUSIONS
4.3.5.3. GLOBAL   SOFTWARE AND SERVICES MARKET
4.3.5.3.1. APPLICATION
4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS 
4.3.5.3.5. KEY CONCLUSIONS
4.4. GLOBAL DIGITAL PCR MARKETBY   END USER
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION 
4.4.5.1. GLOBAL    RESEARCH LABORATORIES AND ACADEMIC INSTITUTES MARKET
4.4.5.1.1. APPLICATION
4.4.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.4. TOP PLAYERS & KEY PRODUCTS 
4.4.5.1.5. KEY CONCLUSIONS
4.4.5.2. GLOBAL    HOSPITALS AND DIAGNOSTIC CENTERS MARKET
4.4.5.2.1. APPLICATION
4.4.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.4. TOP PLAYERS & KEY PRODUCTS 
4.4.5.2.5. KEY CONCLUSIONS
4.4.5.3. GLOBAL    PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET
4.4.5.3.1. APPLICATION
4.4.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.3.4. TOP PLAYERS & KEY PRODUCTS 
4.4.5.3.5. KEY CONCLUSIONS
4.4.5.4. GLOBAL    CLINICAL RESEARCH ORGANIZATIONS MARKET
4.4.5.4.1. APPLICATION
4.4.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.4.4. TOP PLAYERS & KEY PRODUCTS 
4.4.5.4.5. KEY CONCLUSIONS
4.4.5.5. GLOBAL    FORENSIC LABORATORIES MARKET
4.4.5.5.1. APPLICATION
4.4.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.5.4. TOP PLAYERS & KEY PRODUCTS 
4.4.5.5.5. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITION 
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL DIGITAL PCR MARKETBY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRIAL END-USER ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. AFFYMETRIX, INC.
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES 
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. AGILENT TECHNOLOGIES, INC.
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES 
7.2.5. SCOT ANALYSIS 
7.2.6. STRATEGIC ANALYSIS
7.3. BIOMÉRIEUX S.A.
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES 
7.3.5. SCOT ANALYSIS
7.3.6. STRATEGIC ANALYSIS
7.4. BIO-RAD LABORATORIES, INC.
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES 
7.4.5. SCOT ANALYSIS
7.4.6. STRATEGIC ANALYSIS
7.5. .    F. HOFFMAN-LA ROCHE LTD
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES 
7.5.5. SCOT ANALYSIS 
7.5.6. STRATEGIC ANALYSIS
7.6. .    FLUIDIGM CORPORATION
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES 
7.6.5. SCOT ANALYSIS 
7.6.6. STRATEGIC ANALYSIS
7.7. .    FORMULATRIX
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES 
7.7.5. SCOT ANALYSIS 
7.7.6. STRATEGIC ANALYSIS
7.8. HONGSHI MEDICAL TECHNOLOGY
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES 
7.8.5. SCOT ANALYSIS 
7.8.6. STRATEGIC ANALYSIS
7.9. .    MDX HEALTH
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES 
7.9.5. SCOT ANALYSIS 
7.9.6. STRATEGIC ANALYSIS
7.10. PACIFIC BIO SCIENCES 
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES 
7.10.5. SCOT ANALYSIS
7.10.6. STRATEGIC ANALYSIS
7.11. QIAGEN N.V.
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES 
7.11.5. SCOT ANALYSIS
7.11.6. STRATEGIC ANALYSIS
7.12. RAINDANCE TECHNOLOGIES, INC.
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES 
7.12.5. SCOT ANALYSIS
7.12.6. STRATEGIC ANALYSIS
7.13. SIGMA-ALDRICH
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES 
7.13.5. SCOT ANALYSIS
7.13.6. STRATEGIC ANALYSIS
7.14. STILLA TECHNOLOGIES
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES 
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS
7.15. TAKARA BIO, INC.
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES 
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL DIGITAL PCR MARKETBY  TECHNOLOGY 2014-2023 ($ MILLION)
2. GLOBAL  DIGITAL PCR (DPCR)  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL  QUANTITATIVE PCR (QPCR)MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL DIGITAL PCR MARKETBY BY PRODUCTS AND SERVICES 2014-2023 ($ MILLION)
5. GLOBAL DPCR INSTRUMENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
6. GLOBAL DPCR REAGENTS AND CONSUMABLES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL DPCR SOFTWARE AND SERVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL DIGITAL PCR MARKETBY APPLICATION  2014-2023 ($ MILLION)
9. GLOBAL DIGITAL PCR CLINICAL APPLICATION BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL DIGITAL PCR RESEARCH APPLICATIONS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL DIGITAL PCR FORENSIC APPLICATIONS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
12. GLOBAL DIGITAL PCR MARKET BY END USER 2014-2023 ($ MILLION)
13. GLOBAL DIGITAL PCR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL DIGITAL PCR HOSPITALS AND DIAGNOSTIC CENTERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
15. GLOBAL DIGITAL PCR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
16.  GLOBAL DIGITAL PCR CLINICAL RESEARCH ORGANIZATIONS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
17. GLOBAL DIGITAL PCR FORENSIC LABORATORIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
18. NORTH AMERICA DPCR MARKET 2014-2023 ($ MILLION)
19. EUROPE DPCR MARKET 2014-2023 ($ MILLION)
20. ASIA PACIFIC DPCR MARKET 2014-2023 ($ MILLION)
21. REST OF THE WORLD DPCR MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL DIGITAL PCR MARKETBY  DIGITAL PCR (DPCR)  MARKET 2014-2023 ($ MILLION)
2. GLOBAL DIGITAL PCR MARKETBY  QUANTITATIVE PCR (QPCR) MARKET 2014-2023 ($ MILLION)
3. GLOBAL DIGITAL PCR MARKETBY  INSTRUMENTS MARKET 2014-2023 ($ MILLION)
4. GLOBAL DIGITAL PCR MARKETBY  DPCR REAGENTS AND CONSUMABLES MARKET 2014-2023 ($ MILLION)
5. GLOBAL DIGITAL PCR MARKETBY  SOFTWARE AND SERVICES MARKET 2014-2023 ($ MILLION)
6. GLOBAL DIGITAL PCR MARKET  CLINICAL APPLICATION MARKET 2014-2023 ($ MILLION)
7. GLOBAL DIGITAL PCR MARKETIN  RESEARCH APPLICATIONS MARKET 2014-2023 ($ MILLION)
8. GLOBAL DIGITAL PCR MARKETIN  FORENSIC APPLICATIONS MARKET 2014-2023 ($ MILLION)
9. GLOBAL DIGITAL PCR MARKET IN  RESEARCH LABORATORIES AND ACADEMIC INSTITUTES MARKET 2014-2023 ($ MILLION)
10. GLOBAL DIGITAL PCR MARKET IN  HOSPITALS AND DIAGNOSTIC CENTERS MARKET 2014-2023 ($ MILLION)
11. GLOBAL DIGITAL PCR MARKET IN  PHARMACEUTICAL AND BIOTECHNOLOGY APPLICATION MARKET 2014-2023 ($ MILLION)
12. GLOBAL DIGITAL PCR MARKET IN CLINICAL RESEARCH ORGANIZATIONS APPLICATION MARKET 2014-2023 ($ MILLION)
13. GLOBAL DIGITAL PCR MARKET  IN FORENSIC LABORATORIES AND BIOTECHNOLOGY APPLICATION MARKET 2014-2023 ($ MILLION)
14. UNITED STATES (U.S.) DPCR MARKET 2014-2023 ($ MILLION)
15. CANADA DPCR MARKET 2014-2023 ($ MILLION)
16. UNITED KINGDOM (UK) DPCR MARKET 2014-2023 ($ MILLION)
17. FRANCE DPCR MARKET 2014-2023 ($ MILLION)
18. GERMANY DPCR MARKET 2014-2023 ($ MILLION)
19. SPAIN DPCR MARKET 2014-2023 ($ MILLION)
20. ROE DPCR MARKET 2014-2023 ($ MILLION)
21. INDIA DPCR MARKET 2014-2023 ($ MILLION)
22. CHINA DPCR MARKET 2014-2023 ($ MILLION)
23. JAPAN DPCR MARKET 2014-2023 ($ MILLION)
24. AUSTRALIA DPCR MARKET 2014-2023 ($ MILLION)
25. ROAPAC DPCR MARKET 2014-2023 ($ MILLION)
26. LATIN AMERICA DPCR MARKET 2014-2023 ($ MILLION)
27. MENA DPCR MARKET 2014-2023 ($ MILLION)
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: sales@occamsresearch.com

 

 

Go To Top
viewthroughconversion